Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAKINUMAB vs CANGRELOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANAKINUMAB vs CANGRELOR: Safety Overview

Metric CANAKINUMAB CANGRELOR
Total FAERS Reports 10,462 323
Deaths Reported 518 71
Death Rate 5.0% 22.0%
Hospitalizations 2,624 48
Average Patient Age 28.8 yrs 64.6 yrs
% Female Patients 55.8% 36.1%
FDA Approval Date N/A Aug 11, 2025
Manufacturer Novartis Pharmaceuticals Corporation Gland Pharma Limited
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription